Follow The Filings

MDXH MDxHealth

MDxHealth earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.18 —
Rev — $27.2M —

Insider trades

Open-market buys and sales by MDXH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MDXH insider trades
  • $1M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. MVM Partners, LLC Director, +1 joint filer
    Buy
    $1M 2,202,643 shares at $0.4500 +47% to stake
    Traded Aug 13 Filed Aug 17
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
SCHEDULE 13D/A — Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
20-F ANNUAL REPORT Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc
6-K REPORT OF FOREIGN PRIVATE ISSUER Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.